1. Home
  2. NOA vs REPL Comparison

NOA vs REPL Comparison

Compare NOA & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NOA

North American Construction Group Ltd. (no par)

HOLD

Current Price

$13.49

Market Cap

371.6M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$10.05

Market Cap

407.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOA
REPL
Founded
1953
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
371.6M
407.1M
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
NOA
REPL
Price
$13.49
$10.05
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$5.67
AVG Volume (30 Days)
67.3K
5.6M
Earning Date
05-13-2026
05-21-2026
Dividend Yield
2.40%
N/A
EPS Growth
N/A
5.25
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.77
N/A
Revenue Next Year
$5.43
N/A
P/E Ratio
$18.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.07
$1.50
52 Week High
$17.68
$13.24

Technical Indicators

Market Signals
Indicator
NOA
REPL
Relative Strength Index (RSI) 42.99 70.08
Support Level $13.26 $9.50
Resistance Level $14.61 $10.71
Average True Range (ATR) 0.40 0.88
MACD -0.03 0.01
Stochastic Oscillator 30.70 68.58

Price Performance

Historical Comparison
NOA
REPL

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: